AVTX Latest Press Releases

-- November 5, 2026 --

Avalo Therapeutics Reports Third Quarter 2026 Financial Results and Recent Business Updates Globe Newswire 7:00 AM

-- November 2, 2026 --

Avalo Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 4:00 PM

-- September 29, 2026 --

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:01 PM

-- September 23, 2026 --

Avalo Therapeutics to Present at the European Academy of Dermatology and Venereology (EADV) 2026 Congress Globe Newswire 7:00 AM

-- September 4, 2026 --

Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4) Globe Newswire 4:05 PM

-- September 3, 2026 --

Avalo Therapeutics to Participate in Upcoming Investor Conferences Globe Newswire 7:00 AM

-- August 6, 2026 --

Avalo Therapeutics Reports Second Quarter 2026 Financial Results and Recent Business Updates Globe Newswire 7:00 AM

-- July 22, 2026 --

Avalo Therapeutics to Participate in the BTIG Biotechnology Conference Globe Newswire 7:00 AM

-- July 7, 2026 --

Avalo Therapeutics to Participate in the Leerink Partners Therapeutics Forum Globe Newswire 7:00 AM

-- June 26, 2026 --

Avalo Therapeutics to Join the Russell 2000 and Russell 3000 Indexes Globe Newswire 7:00 AM

-- June 23, 2026 --

Avalo Therapeutics Appoints Ron Philip to Board of Directors Globe Newswire 7:00 AM

-- June 16, 2026 --

Avalo Therapeutics Expands Pipeline with AVTX-010, a Long-Acting Next-Generation Anti-IL-1 Antibody Globe Newswire 7:00 AM

Market Data Delayed 15 Minutes